AVITA Medical, Inc.
RCEL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $331,303 | $347,545 | $165,001 | $291,791 |
| - Cash | $14,050 | $22,118 | $18,164 | $55,511 |
| + Debt | $45,985 | $42,409 | $918 | $1,638 |
| Enterprise Value | $363,238 | $367,836 | $147,755 | $237,918 |
| Revenue | $64,251 | $50,143 | $34,421 | $33,025 |
| % Growth | 28.1% | 45.7% | 4.2% | – |
| Gross Profit | $55,157 | $42,363 | $28,380 | $26,921 |
| % Margin | 85.8% | 84.5% | 82.4% | 81.5% |
| EBITDA | -$55,304 | -$33,540 | -$26,045 | -$24,403 |
| % Margin | -86.1% | -66.9% | -75.7% | -73.9% |
| Net Income | -$61,845 | -$35,381 | -$26,665 | -$25,142 |
| % Margin | -96.3% | -70.6% | -77.5% | -76.1% |
| EPS Diluted | -2.39 | -1.4 | -1.57 | -1.03 |
| % Growth | -70.7% | 10.8% | -52.4% | – |
| Operating Cash Flow | -$48,939 | -$38,011 | -$19,090 | -$18,037 |
| Capital Expenditures | -$9,333 | -$1,447 | -$525 | -$487 |
| Free Cash Flow | -$58,272 | -$39,458 | -$19,615 | -$18,524 |